Efficacy and safety of Ombitasvir/Paritaprevir/Ritonavir in chronic hepatitis C patients
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Ombitasvir/paritaprevir/ritonavir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Nov 2017 Status changed from recruiting to completed.
- 28 May 2016 New trial record